EVENTS

2026/06/19
‘ζ‚R‚R‰ρHABŒ€‹†‹@\Šwp”N‰ο

2026/01/01
2026”NŒ³’UŽOd‘εŠw‘OˆΙ¨˜p‰“ϊo

2025/12/10
2026”N1ŒŽ21“ϊ(…)13:00-16:30AIƒvƒŒƒVƒWƒ‡ƒ“PDXZƒZƒ~ƒi[

2025/12/09
Cuvier duct PDXZ ‚Μ ŽΐŒ±“I“]ˆΪƒAƒbƒZƒC (Experimental Metastasis Assay)

2025/12/08
PDXZ‚Ι‚¨‚―‚ιŽξᇑB—}§ŽŽŒ± (Tumor Growth Inhibition)

tdiscovery of stanniocalcin1 as cardiotoxic defence gene

                     
2024/04/25

We have discovered stanniocalcin1 as cardiotoxic defence gene in 2015. the potential clinical applications of stanniocalcin in oncocardiology include its use as a biomarker for cancer therapy-induced cardiotoxicity, its potential as a therapeutic target for cardioprotection, and its role in regulating calcium homeostasis, which may be relevant for managing calcium-related cardiovascular complications in cancer patients.

ŠΦ˜AƒŠƒ“ƒN

ŽOd‘εŠw‘εŠw‰@ˆγŠwŒnŒ€‹†‰ΘƒVƒXƒeƒ€ƒY–ς—Šw

ŽOd‘εŠwƒƒfƒBƒJƒ‹ƒ[ƒuƒ‰ƒtƒBƒbƒVƒ…Œ€‹†ƒZƒ“ƒ^[

ŠΦ˜Aƒtƒ@ƒCƒ‹

discovery of stanniocalcin1 as cardiotoxic defence gene

high-throughput screening for cardiotoxicology